B-MoGen Biotechnologies Inc — Department of Defense SBIR Phase I: SB163-003
B-MoGen Biotechnologies Inc — SBIR Phase I award from Department of Defense.
- Amount
- $149,431
- Agency
- Department of Defense · Defense Advanced Research Projects Agency
- Program / Phase
- SBIR · Phase I
- Topic
- SB163-003
- Solicitation
- 2016.3
- NAICS
- —
- Place of performance
- MN
- Period
- 2017-03-21 → 2017-12-20
Description
This proposal leverages our expertise in genetic engineering in general, our success in multiplex gene editing, and nanoparticle-based gene delivery to achieve targeted base editing of hepatitis B virus (HBV) genomes in infected cells. Not only will this...